Sort
48,018 grants matching “immunotherapy”
SUMO Modification and Cancer Therapy
$486,964Yuan Chen · University Of California, San Diego · R01 · FY2024 · CA
Inflammation and immunity in the crucible of premalignancy
$486,936Adrian Erlebacher · New York University School Of Medicine · R01 · FY2015 · CA
An epigenomic approach to reactivate latent HIV
$486,935Qin Feng · University Of Houston · R33 · FY2018 · AI
Transplant EBV Disease: Pathogenesis and Immunotherapy
$486,897University Of Pittsburgh At Pittsburgh · P50 · FY2005 · HL
Transport Oncophysics Core
$486,823Mauro Ferrari · Methodist Hospital Research Institute · U54 · FY2016 · CA
Acute Kidney Injury and Double Negative T Cells
$486,804Abdel Hamad · Johns Hopkins University · R01 · FY2023 · DK
Endothelial cells regulate immune reconstitution after hematopoietic stem cell transplantation
$486,797Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Fatty acid signaling in the pancreatic tumor microenvironment
$486,750Mara H. Sherman · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Fatty acid signaling in the pancreatic tumor microenvironment
$486,750Mara H. Sherman · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Functional analysis of the immune landscape in IDH mutant gliomas
$486,750Viviane Tabar · Sloan-Kettering Inst Can Research · R21 · FY2021 · NS
Genetic dissection of Id3-mediated pathways in gamma/delta lineage development
$486,748Yuan Zhuang · Research Inst Of Fox Chase Can Ctr · P01 · FY2016 · AI
Definition of Immune Infiltrate Phenotype and DNA Damage Response Deficits Across Diverse Murine Mammary Carcinomas
$486,710Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2019 · CA
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis
$486,640Tatiana Kisseleva · University Of California, San Diego · R01 · FY2025 · DK
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis
$486,640Tatiana Kisseleva · University Of California, San Diego · R01 · FY2021 · DK
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis
$486,640Tatiana Kisseleva · University Of California, San Diego · R01 · FY2022 · DK
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis
$486,640Tatiana Kisseleva · University Of California, San Diego · R01 · FY2023 · DK
Achieving Therapeutic Antigent-Specific Tolerance in Type 1 Diabetes
$486,604Matthias G. Von Herrath · La Jolla Institute For Immunology · U01 · FY2011 · DK
Clinical-Virology Core
$486,601Kari C. Nadeau · Stanford University · U54 · FY2022 · CA
Developing new therapeutic strategies for pediatric tumors that lack clinically actionable mutations
$486,599Paul Geeleher · St. Jude Children'S Research Hospital · R01 · FY2021 · CA
Immunometabolic pathways enabled by PARP inhibition in breast cancer
$486,593Jennifer L. Guerriero · Brigham And Women'S Hospital · R37 · FY2025 · CA
NGF recruits nerve fibers to reprogram an immunosuppressive microenvironment in melanoma
$486,559Xiao-Fan Wang · Duke University · R01 · FY2024 · CA
eRapa for bladder cancer prevention
$486,532Robert Scott Svatek · University Of Texas Hlth Science Center · R01 · FY2020 · CA
Targeting the Epigenome for Lung Cancer Therapy
$486,527David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
Epigenetic Mechanisms of Gene Expression in Lung Cancer Cells
$486,527David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Proteolysis-targeting chimera against BCL-XL inhibits breast cancer metastasis
$486,504Weizhou Zhang · University Of Florida · R01 · FY2024 · CA